Shanghai Hile Bio-tech (603718) — Long-term Investment Intensity
Shanghai Hile Bio-tech (603718) has a Long-term Investment Intensity of 1.3% as of September 2019. Long-term investments of CN¥24.25 Million represent 1.3% of total assets of CN¥1.83 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Shanghai Hile Bio-tech liquidity resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Shanghai Hile Bio-tech Long-term Investment Intensity (2016–2018)
This chart shows how Shanghai Hile Bio-tech's Long-term Investment Intensity has evolved across 3 annual periods from 2016 to 2018. As of September 2019, the intensity stands at 1.3%, reflecting long-term investments of CN¥24.25 Million against total assets of CN¥1.83 Billion CNY. For the complete balance sheet picture, see Shanghai Hile Bio-tech assets under control.
Annual Long-term Investment Intensity for Shanghai Hile Bio-tech (2016–2018)
The table below presents the year-by-year Long-term Investment Intensity for Shanghai Hile Bio-tech from 2016 to 2018, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Shanghai Hile Bio-tech (603718) financial obligations for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 1.4% | CN¥24.77 Million | CN¥1.75 Billion | ▼ -5.7 pp |
| 2017 | 7.2% | CN¥114.64 Million | CN¥1.60 Billion | ▲ +6.5 pp |
| 2016 | 0.7% | CN¥10.00 Million | CN¥1.48 Billion | — |